NCT05275868
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05275868
Title Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | CHE

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Wash U School of Medicine St Louis Missouri 63110 United States Details
NYU School of Medicine New York New York 10015 United States Details
Memorial Sloan Kettering Onc. Dept New York New York 10017 United States Details
Memorial Sloan Kettering New York New York 10017 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Novartis Investigative Site Frankfurt am Main Hesse 60590 Germany Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Chuo Ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Geneva CH 1211 Switzerland Details
Novartis Investigative Site Sankt Gallen 9007 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field